Late last year, Mossberg made news when it introduced the Mossberg Modern Rifle (MMR), an affordable AR-style rifle chambered ... lacks some of the portability of a collapsible, six-position stock, but it delivers a better cheek weld when shooting.
and $2.1 billion for MMR (about $50 per share in cash and stock), making it a $9 billion acquisition in total. McMoRan Exploration used to be a part of Freeport-McMoRan, but was spun off into a separate publicly-traded company. Now, …
Navi Mumbai: The irrigation department will impose a 7% cut for four agencies supplying daily drinking water to a vast area in MMR, comprising of seven major ... in Barvi and Tata Andre dam whose water stock may last till July 15. The department handles ...
McMoRan Exploration Co. (NYSE: MMR) is seeing almost a 100% above-normal trading volume in its shares today, but the real news is in the stock options trading volume today. The headlines were a bit misleading The WSJ noted in its “movers” section ...
Roche Holdings AG RHHBY recently announced FDA clearance for the VENTANA MMR IHC Panel for immunohistochemistry (IHC ... The FDA approval further broadens Roche’s diagnostic portfolio. Roche’s stock has rallied 3.8% year to date compared with industry ...
Behind such headline figures lie a series of negative influences, including worsened housing affordability, rigorous ‘stress testing’, shortage of stock and, of course, MMR-driven tighter affordability restrictions. So some short-term pain for longer ...
ST: Saratoga was recently listed on the NYSE Amex stock exchange. It was a great day for the company ... The Davey Jones well, drilled by McMoRan Exploration Co. (NYSE:MMR) is in the process of bringing a flow-testing unit online over the next few weeks.
Over the last four days of the month, Toney—through a separate fund that MMR managed—placed numerous buy orders for a thinly traded over-the-counter stock in which MedCap already was heavily invested. Toney's buying pressure caused the stock price to ...
Roche Holdings AG RHHBY recently announced FDA clearance for the VENTANA MMR IHC Panel for immunohistochemistry (IHC ... The FDA approval further broadens Roche’s diagnostic portfolio. Roche’s stock has rallied 3.8% year to date compared with industry ...
The panel of five assays includes four that target MMR proteins MLH1, MSH2 ... The FDA approval further broadens Roche’s diagnostic portfolio. Roche’s stock has rallied 3.8% year to date compared with industry’s gain of 17.7%. Apart from providing ...
Finance Yahoo · 7mon